Our results establish PPM1B as a potential tumor suppressor in lung cancer, with significantly reduced expression observed in both SCC and ADC tissues compared to normal lung tissue, with a more pronounced, 0.31-fold (p = 0.029) decrease in SCC (Figure 1A). Here, PPM1B is linked to lung carcinoma.